(MENAFN- GlobeNewsWire - Nasdaq) Dublin, Nov. 03, 2026 (GLOBE NEWSWIRE) -- "Cell Dissociation - Global Strategic Business Report 2026" has been added to ResearchAndMarkets.com's offering. The global cell dissociation market was valued at US$249.5 million in 2025 and is projected to reach US$587.4 million by 2032, expanding at a compound annual growth rate (CAGR) of 13% during the forecast period. Market growth is being supported by advances in biotechnology, rising investment in personalized medicine, expanding single-cell research, and increasing demand for cell-based therapies.
Cell Dissociation Market Trends and Growth Drivers
Cell dissociation remains integral to biomedical research, drug development, regenerative medicine, tissue engineering, flow cytometry, stem cell research, and single-cell sequencing. Reliable dissociation protocols enable researchers to obtain viable cells for downstream culturing, molecular analysis, cellular reprogramming, drug screening, and therapeutic development.
Demand is particularly strong in cancer research, where tumor samples are processed into individual cells for molecular profiling and treatment-response studies. Cell dissociation is also increasingly important in immunology, regenerative medicine, and advanced therapy development, including CAR-T cell therapies and stem cell transplantation. These applications require dissociation methods that preserve cell viability, membrane integrity, surface markers, and biological function.
The rapid adoption of single-cell genomics and proteomics is creating additional opportunities for cell dissociation product manufacturers. Researchers require consistent cell isolation methods to examine cellular heterogeneity, disease progression, immune responses, and treatment resistance. As pharmaceutical and biotechnology companies expand precision medicine programs, demand for optimized enzymatic and non-enzymatic dissociation products is expected to accelerate.
Technological Innovation Strengthens Market Expansion
Technological advances are improving the efficiency, reproducibility, and scalability of cell dissociation. New enzymatic formulations can process resistant, fibrotic, and collagen-rich tissues more effectively while reducing exposure time and preserving viable cell yields. Non-enzymatic products are also gaining adoption in applications requiring minimal disruption to cell-surface proteins, including receptor analysis and flow cytometry.
Automation, high-throughput processing, microfluidics, and mechanical dissociation systems are further transforming laboratory workflows. These technologies allow multiple samples to be processed with greater consistency and can reduce the risk of enzyme-induced cellular damage. Their ability to support complex brain, liver, tumor, and connective tissue samples is broadening the addressable market across research and clinical environments.
Additional growth is expected from 3D bioprinting and tissue engineering, where accurate control of cell populations is essential for creating complex biological structures. Increasing healthcare expenditure, the rising prevalence of cancer and chronic disease, and sustained investment in drug discovery are also contributing to favorable market conditions.
Market Segmentation and Geographic Coverage
Product type: Enzymatic dissociation products, non-enzymatic dissociation products, and instruments and accessories. Tissue: Connective tissue, epithelial tissue, and other tissues. End use: Pharmaceutical and biotechnology companies, research and academic institutes, and other end users. Geographic coverage: United States, Canada, Japan, China, Europe, Asia-Pacific, and the Rest of World.
Key Cell Dissociation Market Insights
The enzymatic dissociation products segment is forecast to reach US$302.2 million by 2032, advancing at a CAGR of 14%. The non-enzymatic dissociation products segment is projected to expand at a CAGR of 12.5% over the analysis period. The United States cell dissociation market was valued at US$73 million in 2025. China is forecast to grow at a CAGR of 12.4%, reaching US$101.9 million by 2032. Japan, Canada, Germany, and the broader Asia-Pacific region are expected to provide additional growth opportunities.
Report Scope and Strategic Value
The report provides independent analysis of annual sales and market forecasts from 2025 through 2032. It examines competitive conditions, regional growth patterns, product demand, emerging applications, and the strategic factors influencing the global cell dissociation industry. The analysis is designed to help organizations identify revenue opportunities, evaluate market entry strategies, assess competitive positioning, and support informed investment decisions.
Key questions addressed include how the global cell dissociation market will evolve through 2032, which product and end-use segments will record the strongest growth, how regional market positions may change, and which technological and commercial developments will influence future demand.
Companies Featured in the Cell Dissociation Market Report
American Type Culture Collection (ATCC) Becton, Dickinson and Company F. Hoffmann-La Roche AG GE Healthcare HiMedia Laboratories Merck KGaA Miltenyi Biotec GmbH PAN-Biotech GmbH STEMCELL Technologies Inc. Thermo Fisher Scientific Inc.
Domain Expert Insights and Report Differentiators
Expert-informed analysis: Integrates perspectives from industry specialists, enterprise leaders, researchers, and academic experts to provide context beyond conventional published research. Early market signals: The report tracks developments emerging from expert discussions, company activity, scientific conferences, and market-relevant events before they are fully reflected in secondary research. Validated intelligence base: Draws on conference sessions, keynote presentations, panel discussions, corporate disclosures, annual reports, institutional publications, and other validated sources. Strategic market direction: Connects emerging signals with market drivers to identify developments likely to influence investment, innovation, and competitive strategy. Company intelligence: Evaluates organizations participating in and shaping the competitive landscape, extending the analysis beyond market-level forecasts. Relevant market share analysis: Assesses competitive structures across major regions where market share data provides meaningful strategic insight.
The report also includes company profiles, detailed regional analysis, competitive insights, and complimentary updates for one year, helping decision-makers remain informed about technological advances, market developments, and evolving opportunities across the global cell dissociation market.
Key Attributes
CONTACT:
CONTACT: ResearchAndMarkets.com
Laura Wood,Senior Press Manager...
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Comments
No comment